Literature DB >> 19172248

How reliable are G-protein-coupled receptor antibodies?

Martin C Michel, Thomas Wieland, Gozoh Tsujimoto.   

Abstract

A cluster of manuscripts in this issue of the Journal highlights a lack of selectivity of 49 antibodies against 19 subtypes of alpha(1)- and beta-adrenoceptors, muscarinic, dopamine and galanin receptors as well as vanilloid (TRPV1) receptors. Taken together these data demonstrate that lack of selectivity appears to be the rule rather than the exception for antibodies against G-protein-coupled and perhaps also other receptors. Thus, the previously often applied validation of such antibodies by the disappearance of staining in the presence of blocking peptide, i.e. the antigen against which the antibody was raised, alone is insufficient to demonstrate specificity. We propose that receptor antibodies should be validated by at least one of the following techniques: a) disappearance of staining in knock-out animals of the target receptor, b) reduction of staining upon knock-down approaches such as siRNA treatment, c) selectivity of staining in immunoblots or immunocytochemistry for the target receptor vs. related subtypes when expressed in the same cell line and/or d) antibodies raised against multiple distinct epitopes of a receptor yielding very similar staining patterns. Other issues of consideration to obtain reliable results based on receptor antibodies in applications such as immunohistochemistry or immunoblotting are also being discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19172248     DOI: 10.1007/s00210-009-0395-y

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

1.  The use of receptor-specific antibodies to study G-protein-coupled receptors.

Authors:  Achla Gupta; Lakshmi A Devi
Journal:  Mt Sinai J Med       Date:  2006-07

2.  Antibodies as valuable neuroscience research tools versus reagents of mass distraction.

Authors:  Kenneth J Rhodes; James S Trimmer
Journal:  J Neurosci       Date:  2006-08-02       Impact factor: 6.167

Review 3.  Embracing emerging paradigms of G protein-coupled receptor agonism and signaling to address airway smooth muscle pathobiology in asthma.

Authors:  Raymond B Penn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-16       Impact factor: 3.000

4.  Lack of specificity of commercially available antisera: better specifications needed.

Authors:  Wisuit Pradidarcheep; Wil T Labruyère; Noshir F Dabhoiwala; Wouter H Lamers
Journal:  J Histochem Cytochem       Date:  2008-09-15       Impact factor: 2.479

Review 5.  Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets.

Authors:  Paul A Insel; Chih-Min Tang; Ines Hahntow; Martin C Michel
Journal:  Biochim Biophys Acta       Date:  2006-10-05

6.  Biochemical and histochemical evidence of nonspecific binding of alpha7nAChR antibodies to mouse brain tissue.

Authors:  Donna L Herber; Emily G Severance; Javier Cuevas; Dave Morgan; Marcia N Gordon
Journal:  J Histochem Cytochem       Date:  2004-10       Impact factor: 2.479

7.  Adaptation to excess acetylcholine by downregulation of adrenoceptors and muscarinic receptors in lungs of acetylcholinesterase knockout mice.

Authors:  Jaromir Myslivecek; Ellen G Duysen; Oksana Lockridge
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-06       Impact factor: 3.000

8.  The detection of the non-M2 muscarinic receptor subtype in the rat heart atria and ventricles.

Authors:  Jaromir Myslivecek; Martin Klein; Martina Novakova; Jan Ricny
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-29       Impact factor: 3.000

9.  Lack of specificity of antibodies directed against human beta-adrenergic receptors.

Authors:  Nazha Hamdani; Jolanda van der Velden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-01-22       Impact factor: 3.000

10.  Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice.

Authors:  Xiaoying Lu; Tamas Bartfai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-01-22       Impact factor: 3.000

View more
  121 in total

1.  Commercially available antibodies against human and murine histamine H₄-receptor lack specificity.

Authors:  Silke Beermann; Roland Seifert; Detlef Neumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-10       Impact factor: 3.000

2.  Serotonin 5-HT2C receptor protein expression is enriched in synaptosomal and post-synaptic compartments of rat cortex.

Authors:  Noelle C Anastasio; Maria Fe Lanfranco; Marcy J Bubar; Patricia K Seitz; Sonja J Stutz; Andrew G McGinnis; Cheryl S Watson; Kathryn A Cunningham
Journal:  J Neurochem       Date:  2010-03-24       Impact factor: 5.372

3.  Cross-receptor interactions between dopamine D2L and neurotensin NTS1 receptors modulate binding affinities of dopaminergics.

Authors:  Susanne Koschatzky; Nuska Tschammer; Peter Gmeiner
Journal:  ACS Chem Neurosci       Date:  2011-04-11       Impact factor: 4.418

4.  Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer.

Authors:  D C Borcherding; W Tong; E R Hugo; D F Barnard; S Fox; K LaSance; E Shaughnessy; N Ben-Jonathan
Journal:  Oncogene       Date:  2015-10-19       Impact factor: 9.867

5.  Selection of recombinant anti-SH3 domain antibodies by high-throughput phage display.

Authors:  Haiming Huang; Nicolas O Economopoulos; Bernard A Liu; Andrea Uetrecht; Jun Gu; Nick Jarvik; Vincent Nadeem; Tony Pawson; Jason Moffat; Shane Miersch; Sachdev S Sidhu
Journal:  Protein Sci       Date:  2015-09-16       Impact factor: 6.725

6.  Localization of Glucagon-Like Peptide-2 Receptor Expression in the Mouse.

Authors:  Bernardo Yusta; Dianne Matthews; Jacqueline A Koehler; Gemma Pujadas; Kiran Deep Kaur; Daniel J Drucker
Journal:  Endocrinology       Date:  2019-08-01       Impact factor: 4.736

Review 7.  Molecular and cellular analysis of human histamine receptor subtypes.

Authors:  Roland Seifert; Andrea Strasser; Erich H Schneider; Detlef Neumann; Stefan Dove; Armin Buschauer
Journal:  Trends Pharmacol Sci       Date:  2012-12-17       Impact factor: 14.819

8.  Sphingosine-1-phosphate elicits receptor-dependent calcium signaling in retinal amacrine cells.

Authors:  Scott Crousillac; Jeremy Colonna; Emily McMains; Jill Sayes Dewey; Evanna Gleason
Journal:  J Neurophysiol       Date:  2009-09-23       Impact factor: 2.714

Review 9.  Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence.

Authors:  Radica Z Alicic; Emily J Cox; Joshua J Neumiller; Katherine R Tuttle
Journal:  Nat Rev Nephrol       Date:  2020-11-20       Impact factor: 28.314

10.  Evaluation of antibodies directed against human protease-activated receptor-2.

Authors:  Mark N Adams; Charles N Pagel; Eleanor J Mackie; John D Hooper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-07-31       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.